General term for rules, including delegated legislation and self-regulation
POPULARITY
Categories
Nurses Out Loud with Jodi O'Malley MSN, RN – FDA approved Moderna's MNEXSPIKE COVID-19 vaccine without placebo trials, while a Cleveland Clinic study found the flu shot may have increased COVID-19 risk. Bureaucratic secrecy, incomplete safety data, and suppressed dissent highlight failing “gold standard” claims. Nurses are urged to question mandates, defend ethical integrity, and steadfastly expose medical deception...
Nurses Out Loud with Jodi O'Malley MSN, RN – FDA approved Moderna's MNEXSPIKE COVID-19 vaccine without placebo trials, while a Cleveland Clinic study found the flu shot may have increased COVID-19 risk. Bureaucratic secrecy, incomplete safety data, and suppressed dissent highlight failing “gold standard” claims. Nurses are urged to question mandates, defend ethical integrity, and steadfastly expose medical deception...
In the latest collaboration between ACRO and TransCelerate BioPharma, Cris McDavid (Senior Director, Global Clinical Operations, Parexel) and Tashan Mistree (Senior Director, Business Operations, Office of Chief Medical Officer, GSK) join this week's episode to discuss the impact of ICH E6(R3) from their different vantage points in the clinical research industry. They dive deeper into their experiences implementing the new guidance at their respective companies, the new opportunities that R3 has created in the partnership between CROs and sponsors, and how they envision the future state of R3 once industry has fully embraced the guidance. FIND ACRO & TRANSCELERATE'S ICH E6(R3) TOOLS & RESOURCES HERE: https://www.acrohealth.org/initiatives-hub/interpreting-ich-e6r3/
ACT Party Leader David Seymour has claimed that 99.5 percent of the submissions received on the Regulatory Standards Bill were "fake" and created using "bots". In-Depth Journalist Ella Stewart reports.
The ACT party leader has claimed 99.5 percent of the submissions on a discussion document about the Regulatory Standards Bill were "fake" and created using "bots". Guyon Espiner spoke to Ingrid Hipkiss.
During the next edition of Monitor Mondays, famed whistleblower attorney Mary Inman, partner at Whistleblower Law, will provide an update on a whistleblower case that some consider “beyond bad.”You'll learn why a Texas rheumatologist who was sentenced to 10 years in prison and three years of supervised release was ordered to forfeit more than $28 million, plus 13 real-estate properties, a jet, and a Maserati GranTurismo sports car.Inman, long considered one of the nation's foremost whistleblower attorneys, will be the program's special guest during the next live edition of the venerable Internet broadcast, coming up at 10 a.m. EST on Monday, June 2, 2025.The long-running broadcast will also include these instantly recognizable features:Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.Field Report: Drew Updike will continue his reporting on efforts by the Trump Administration to intervene in healthcare issues – namely the Centers for Medicare & Medicaid Services (CMS) Form 64 related to migrants and Medicaid.
In this high-voltage episode of American Potential, host David From sits down with Rachel Gleason, Executive Director of the Pennsylvania Coal Alliance, to discuss the future of coal, the reliability of America's power grid, and the consequences of top-down energy policy. Gleason gives a behind-the-scenes look at how federal and state regulations have systematically dismantled coal-fired generation in Pennsylvania—once a powerhouse of domestic energy—and how some of the most reliable plants are now being forced offline by policies driven more by politics than reality. She explains how President Trump's recent executive orders are reversing course by removing oppressive regulations and restoring the planning certainty needed to invest in energy production again. From the Clean Power Plan to the Mercury and Air Toxics Standards, Rachel details the flawed data and hidden costs behind these rules and how they've crippled long-term investment in reliable, base-load energy. She also covers the ongoing legal battle over Pennsylvania's attempt to join the Regional Greenhouse Gas Initiative (RGGI)—a de facto carbon tax that could raise costs while other states like Maryland simply import energy they refuse to produce. Gleason and From also examine the growing energy demand from AI and data centers, and why intermittent renewables and small nuclear reactors aren't ready to meet that need. Gleason makes a strong case for a diversified, “all-of-the-above” energy approach—one where coal continues to play a vital role in national security, economic growth, and grid reliability. If you care about affordable energy, American jobs, and ending the political war on coal, this episode is essential listening.
On this episode of "The Federalist Radio Hour," Clyde Wayne Crews, the Fred L. Smith fellow in regulatory studies at the Competitive Enterprise Institute, joins Federalist Senior Elections Correspondent Matt Kittle to discuss the expansion of executive action and break down how the resulting overregulation is costing Americans thousands of dollars every year. Read Crews' “Ten Thousand Commandments" report here. If you care about combating the corrupt media that continue to inflict devastating damage, please give a gift to help The Federalist do the real journalism America needs.
On this episode of “The Federalist Radio Hour,” Clyde Wayne Crews, the Fred L. Smith fellow in regulatory studies at the Competitive Enterprise Institute, joins Federalist Senior Elections Correspondent Matt Kittle to discuss the expansion of executive action and break down how the resulting overregulation is costing Americans thousands of dollars every year. Read Crews' […]
FMCSA's effort to cut a number of regulations is targeting rules that could be eliminated with little to no impact on highway safety. Also, the annual American Truck Historical Society National Convention and Antique Truck Show kicks off next week in Wisconsin's state capital. And several states are working on bills that would affect the move toward autonomous trucks, while Oregon debates two versions of road funding. 0:00 – Newscast 10:05 – Regulatory rollback targets rules that don't affect safety 24:32 – Nation's biggest antique truck show just down the road 39:32 – States taking a closer look at autonomous trucks
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we sat down with Shreya Mehta, co-founder and CEO of Zenflow.Zenflow is a medical device company focused on treating benign prostatic hyperplasia (BPH). A biomedical engineer, Shreya brings over 15 years of experience in medtech, including serving as a lead reviewer at the FDA, where she specialized in cardiovascular devices. Shreya co-founded Zenflow in 2014 out of the Stanford Biodesign Innovation Fellowship. The company was one of the first medical device startups backed by Y Combinator and also received early support from StartX and the UCSF Rosenman Institute at QB3.Shreya's experience at Zenflow reveals strategies for grounding innovation in patient needs, building productive FDA relationships, and leveraging accelerator programs to transform academic concepts into viable businesses.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Shreya Mehta.
In this episode of The Consumer Finance Podcast, Chris Willis and Lori Sommerfield discuss the Consumer Financial Protection Bureau's (CFPB) recent withdrawal of more than 60 pieces of informal guidance, focusing on those related to fair lending and unfair, deceptive, or abusive acts or practices (UDAAP) issues. This conversation highlights key pieces of guidance that have been rescinded, including those concerning adverse action notices and abusive practices, in addition to insights on how these developments might influence the CFPB's enforcement priorities moving forward. This episode is part of a series across multiple podcasts from our Consumer Financial Services practice regarding the recent CFPB advisory withdrawals, and their impact in various areas.
This episode brings the heat on so-called “financial educators” masquerading as fiduciaries while hawking high-commission indexed annuities. Don and Tom dissect the misleading promises of 9% guaranteed returns, break down real disclosure numbers, and expose the enormous commissions driving these “recommendations.” Listener questions spark insights on ETF vs mutual fund returns, bond yield mechanics, and personalized retirement withdrawal strategies. Oh, and say goodbye to the penny—it's headed for extinction. 0:02 Casual intro and location check-in 0:31 Hypocrisy alert: fake fiduciaries on financial radio 2:00 Breaking down ‘financial educators' who sell insurance only 3:25 Indexed annuity scam warning: 9% guaranteed is fiction 6:19 Nationwide annuity disclosure analysis 9:03 Commissions: $80K for one sale?! 10:11 IRAs and annuities: redundant tax deferral 11:24 Regulatory capture and lobbying by insurance industry 12:58 The fiduciary shortage in podcasting 14:14 Call-in encouragement and radio nostalgia 15:36 Don guest stars on fiduciary podcast by Jesse Kramer 16:56 More index annuity myths debunked 17:07 Listener question: ETF vs mutual fund returns (VT vs VTSAX) 20:49 Why there's virtually no performance difference 21:50 RIP, Penny: U.S. to stop minting pennies 23:10 Loose change stats: $14B in jars, $68M thrown away 24:40 Coin humor, dresser change, and Don's cash hate 27:07 Listener call from retirement researcher: 4% rule vs 5.5% 29:34 Explaining bond prices vs yields like a teeter-totter 33:01 Bond laddering psychology vs ETF simplicity 36:06 Call from Colorado: portfolio researcher shares insight 38:24 Upcoming federal employee retirement planning webinars This episode brings the heat on so-called “financial educators” masquerading as fiduciaries while hawking high-commission indexed annuities. Don and Tom dissect the misleading promises of 9% guaranteed returns, break down real disclosure numbers, and expose the enormous commissions driving these “recommendations.” Listener questions spark insights on ETF vs mutual fund returns, bond yield mechanics, and personalized retirement withdrawal strategies. Oh, and say goodbye to the penny—it's headed for extinction. “9% Guaranteed? Yeah, Right.” “Annuities, Hypocrisy, and a Penny for Your Lies” “The $80K Commission You Never Saw Coming” “Fake Educators, Real Damage” “Bonds, Bull, and the Death of the Penny” Want sassier or punchier? I've got reserves. Scene: A retro 1950s-style classroom. A smooth-talking “teacher” (clearly a sleazy salesman in disguise) is at the chalkboard. The chalkboard reads “9% GUARANTEED!” in big bold letters. Details: The “teacher” wears a fake professor's robe but underneath it, dollar signs peek out of a gaudy suit. In the corner, a “fiduciary” badge sits untouched on the desk. A shocked student (maybe a piggy bank with arms) raises its hand in horror. Light sepia-toned filter, mid-century vibe, logo space top left clear. Ready for art now? Say the word and I'll whip up the image. Want to punch up the summary or swap out a title? I'm yours.
Federal agencies expanding their power beyond congressional intent? Unelected bureaucrats making policy decisions? Regulatory whiplash?! According to the litigants urging the Supreme Court to strike down the Chevron doctrine in the Loper Bright case, those were the harms Americans would continue to face if Chevron deference were allowed to continue. But striking down the pivotal legal principle that had been in place for 40 years would bring its own risks, defenders of Chevron argued. Scientific and technical decisions would need to be made by judges with no specialized expertise. Regulatory uncertainty would soar, as thousands of existing rules face new challenges. And the Supreme Court itself could be forced to become, as Justice Ketanji Brown Jackson put it, "uber-legislators." In part two of our episode on Loper Bright, the high court ostensibly considers the plight of the herring fishermen, but actually looks to decide whether to abandon the Chevron doctrine once and for all.Stylebook flag Featured Guests: Ryan Mulvey, counsel with the Cause of Action Institute Jeff Kaelin, director of sustainability and government relations at Lund's Fisheries Wayne Reichle, President of Lund's Fisheries Gillian Metzger, Harlan Fiske Stone Professor of constitutional law at Columbia University Lydia Wheeler, co-host of Cases and Controversies & Supreme Court reporter for Bloomberg Law Greg Stohr, co-host of Cases and Controversies & Supreme Court reporter for Bloomberg News Kimberly Robinson, co-host of Cases and Controversies & Supreme Court reporter for Bloomberg Law *** Hosted and produced by Matthew S. Schwartz Editor/Executive Producer: Josh Block Cover Art: Jonathan Hurtarte Special thanks to Tom Taylor, David Schultz, Paul Detrick, Isabel Gottlieb, and Matt's baby for their vocal performances.
Last Thursday Budget 2025, the “Growth” Budget, was announced. As part of the Budget, there were significant changes to Kiwisaver. There are also new eligibility limits for 18 and 19-year-olds to access benefits, based on parental income. And the ACT Party's Regulatory Standards Bill has passed its first reading and is now before the Finance and Expenditure Committee. The bill has been criticised for its potential effect on the place of Te Tiriti o Waitangi in our laws. For our weekly catch-up with the Labour Party, Wire Host Caeden spoke with Shanan Halbert about both of these issues.
Ditch the Suits - Financial, Investment, & Retirement Planning
In this episode, Travis and Steve delve into the complexities of tariffs, egg prices, and the broader implications for financial futures. They challenge common narratives surrounding these topics, emphasizing the importance of understanding the underlying factors affecting prices and regulations. The conversation highlights the role of supply issues, regulatory policies, and the misconceptions surrounding tariffs, ultimately advocating for a more informed perspective on economic issues. One key is Travis stating, "Awareness of the media agendas is essential for clarity and olitical conversations should be rooted in intelligence, not vitriol."They explore how tariffs serve as a mechanism for realigning competitive balance and discuss the importance of supporting local economies. The conversation also touches on investment strategies in a changing market and the broader implications of U.S. economic policies on global relations. Key TakeawaysEgg prices are high due to supply issues, not tariffs.Panic buying during crises can exacerbate price increases.Regulatory policies often dictate agricultural practices.Tariffs are a common tool used by many countries.The U.S. is not unique in its use of tariffs.Free trade, as commonly understood, does not exist.Understanding tariffs is crucial for informed financial decisions.There are opportunities in economic downturns.Emotional responses to economic news can cloud judgment.Sleeping on an issue can provide clarity and reduce emotional reactions.Tariffs are often misunderstood; they are not a direct tax on consumers.Local economies benefit when consumers prioritize local products.Investment strategies should consider the shifting dynamics of global trade.The U.S. economy is a significant player in the global market.Understanding tariffs can help consumers make informed choices.Consumer behavior is influenced by pricing and product quality.Economic policies can create opportunities for local businesses._________________________________________
Dorrie Dils, President of the Association of Organ Procurement Organizations, joins the podcast to discuss major changes in federal oversight of OPOs and what they mean for the transplant community.CBS News Video Story: https://www.cbsnews.com/video/a-final...CBS News Print Story: https://www.cbsnews.com/organdonors/New York Times Article: https://www.nytimes.com/interactive/2...
Igor Neumann, co-founder of Firefish, discusses the innovative approach of their Bitcoin lending platform. Firefish operates as a decentralized marketplace connecting borrowers and lenders, allowing users to leverage their Bitcoin as collateral for loans. Igor explains the unique features of their protocol, the loan terms, user demographics, and the growing interest in Bitcoin collateralized loans. He also addresses the technical aspects of their platform, including liquidation processes and compliance with regulations, while highlighting the evolving landscape of Bitcoin lending in the EU.Takeaways
In the next installment of the Big Ideas for Smaller Government series, host David From welcomes back Jeremiah Mosteller, Policy Director at Americans for Prosperity, to discuss how Congress can take bold action to rein in runaway federal agencies, eliminate wasteful spending, and make key regulatory reforms permanent. Jeremiah breaks down why popular executive orders from the previous administration—like those promoting transparency and accountability—won't last unless Congress acts. He explains how legislation such as the Guidance Out of Darkness Act, the REINS Act, and the Reorganizing Government Act can prevent bureaucratic overreach, slash unnecessary regulations, and save taxpayers billions. This episode pulls back the curtain on how hidden guidance documents function as backdoor regulation and how bloated rulemaking fuels agency growth. From shrinking budgets to restoring constitutional authority, Jeremiah outlines what's needed to protect the gains of recent reforms—and why time is running out. If you care about limiting government, cutting waste, and preserving individual liberty, this is a conversation you won't want to miss.
In this episode, Carmen Bellebna will share with us the journey of deepeye Medical to implement the EU AI act requirements in parallel with the EU MDR certification. We will review first what is the AI ACT for those that are still not aware and also all the challenges that deepeye went through to be able to get the EU MDR certification. Who is Carmen Bellebna? Carmen Bellebna is a Regulatory Affairs and Quality Management expert at deepeye Medical, a medtech company pioneering AI-driven solutions for ophthalmology. With a strong background in implementing EU regulatory frameworks, Carmen has been closely following the evolution of the Artificial Intelligence Act (AI Act) and its intersection with the Medical Device Regulation (MDR). She has played a key role in integrating AI-specific compliance strategies into deepeye's QMS, ensuring alignment with both MDR and upcoming AI requirements. Carmen recently delivered a well-received presentation at the Outsourcing in Clinical Trials (OCT) conference in Munich, where she shared hands-on insights and practical tips for operationalizing AIA obligations within a regulated medtech environment. Who is Monir El Azzouzi? Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more. Link Carmen Bellebna LinkedIn: https://www.linkedin.com/in/men-be-a1828a81/ Social Media to follow Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi Twitter: https://twitter.com/elazzouzim Pinterest: https://www.pinterest.com/easymedicaldevice Instagram: https://www.instagram.com/easymedicaldevice Authorized Representative and Importer services:https://easymedicaldevice.com/authorised-representative-and-importer/
Should You Invest in Chairside Milling or 3D Printing? How do milling and printing compare in durability and cost? Which option provides the best long-term ROI for your workflow? In this deep dive, Dr. Rustom Moopen shares his experience with CEREC, ExoCAD, and in-house fabrication, breaking down the real benefits and limitations of both technologies. From restoration strength to efficiency and investment costs, this episode unpacks what every dentist needs to know before taking the leap into milling, printing, and CAD/CAM workflows. https://youtu.be/fgQnrDfXnqI Watch PDP224 on Youtube Protrusive Dental Pearl: Achieving the same effect (of the ‘Soft Clamp' by Kerr) with a metal clamp without requiring a potentially painful palatal injection - Dr. Jo Cape (Protruserati) suggests using a cotton bud to apply topical anesthetic to the gingiva where the clamp will be placed, leaving it for a minute, improving patient comfort! Key TakeAway: Investing in technology like milling can lead to a measurable ROI. Time management is crucial in dental procedures for efficiency. Milling is a subtractive process, while printing is additive. Mentorship is often more valuable than formal courses. The dental industry is evolving with new technologies. Understanding the nuances of dental procedures can enhance practice. Early adoption of technology can set a practice apart. Milling and printing serve different purposes in dental work. Mock-ups can save time and improve patient satisfaction. Milling offers more reliability than printing for dental applications. The choice between milling and printing depends on personal preference and practice needs. Milled composites have a proven track record of durability. Printed splints may not hold up under heavy use. Investing in milling technology can enhance practice efficiency. Design software plays a crucial role in modern dentistry. Understanding the strengths and weaknesses of each method is essential for success. Investing in dental software can be costly but worthwhile. Learning design software is crucial for modern dentistry. Milling is generally superior to printing for final restorations. Regulatory considerations are important for in-house lab work. Choosing the right milling equipment depends on practice needs. Training and mentorship are essential for mastering dental technology. Highlights of this episode: 03:29 Protrusive Dental Pearl 04:59 Meet Dr. Rustom Moopen: Journey of Learning and Mentorship 09:21 Early Adoption of CAD/CAM Technology 11:54 The Practicalities of Chairside Milling 19:01 Emax Chairside Workflow 23:10 Printing vs. Milling: Understanding the Basics 26:48 Printed Mock-Ups and Workflow Integration 29:43 Comparing Milled and Printed Composites 32:07 The Future of Splints: Milling vs. Printing 35:50 Choices After Scanning a Tooth 37:16 Milling vs. Printing: Pros and Cons 41:11 Design Software and Training 49:28 Practical Applications of 3D Printing 53:42 Investing in Digital Dentistry 55:35 Printed Restorations vs Direct Composite 56:45 Regulatory Concerns 58:31 Investing in Milling Units 01:00:53 Ideal Candidates for Milling 01:03:49 Training and Resources If you enjoyed this episode, don't miss PDP137 – Q&A with a Dental Technician! #PDPMainEpisodes #BreadandButterDentistry This episode is eligible for 1 CE credit via the quiz on Protrusive Guidance. This episode meets GDC Outcomes B and C. AGD Subject Code: 130 ELECTIVES (Product/technology training) This episode aimed to provide an in-depth understanding of the fundamentals of 3D printing, milling, and digital dentistry, enabling clinicians to integrate these technologies efficiently into their workflow for improved precision, cost-effectiveness, and patient outcomes. Dentists will be able to - 1. Differentiate between 3D printing and milling,
Welcome to a special edition of We get work®, recorded live from Workplace Horizons 2025 in New York City, Jackson Lewis's annual Labor and Employment Law Conference. Over 500 representatives from 260 companies gathered together to share valuable insights and best practices on workplace law issues impacting their business today. Here's your personal invitation to get the insights from the conference, delivered directly to you.
Episode Info The Insurance Industry is facing a number of challenges today. And yet the number of strategies tools we can use to overcome those challenges is equally numerous. That's the spirit of the conversations my good friend Nick Lamparelli and I get into whenever we talk, and now, you get to hear what we talk about because we got together to take over Dave Wechsler's InsurTech Rap a couple of weeks ago, and I am releasing that episode on my show for all of you! Highlights from the Show The interview delves into the current challenges and innovations within the insurance market, focusing on the years 2023 and 2024. Key issues discussed include the impact of inflation, tariffs, and natural catastrophes on the industry. The conversation highlights the structural changes in the market, particularly the broken cycle of rate adjustments post-crises, and the ongoing struggle to balance profitability with affordability for both carriers and consumers. Regulatory challenges, such as difficulties in obtaining rate approvals, are examined, alongside the industry's frustration with continuous rate increases. The discussion also explores innovative solutions like parametric insurance, which offers a viable alternative to traditional models, and emphasizes the importance of diversification in business models, especially for mutual insurers. The interview touches on the economic effects of tariffs on trade flow and currency attractiveness, as well as the long-term cost of capital. Audience interaction enriches the conversation, providing additional insights into market challenges and potential solutions. The session concludes with gratitude towards participants and a teaser for future discussions on community-based insurance solutions. Key Points: Market Dynamics and Challenges: The conversation explores the structural changes in the insurance market, emphasizing the broken cycle of rate adjustments following crises. Challenges in finding a balance between profitability and affordability for carriers and consumers are highlighted. Regulatory and Rate Issues: The difficulty in obtaining rate approvals and the impact of regulatory actions on market dynamics are discussed. The conversation touches on the frustration within the industry regarding continuous rate increases and the need for alternative solutions. Parametric Insurance Solutions: The rise of parametric insurance as a viable alternative to traditional models is explored, noting its benefits and cost implications. Diversification and Innovation: The importance of diversification in business models, especially for long-standing mutual insurers, is emphasized. The potential for creative solutions like reciprocal models and community-based insurance solutions is discussed. Impact of Tariffs and Economic Factors: The conversation delves into the effects of tariffs on trade flow, currency attractiveness, and the long-term cost of capital. This episode is brought to you by The Future of Insurance book series (future-of-insurance.com) from Bryan Falchuk. Follow the podcast at future-of-insurance.com/podcast for more details and other episodes. Music courtesy of Hyperbeat Music, available to stream or download on Spotify, Apple Music, and Amazon Music and more.
Matt Loszak is CEO and co-founder of Aalo Atomics, a startup designing 50-megawatt nuclear power plants made of pods of five 10-megawatt reactors each, targeting the data center market. Inspired by the MARVEL test reactor that his CTO Yasir Arafat led at Idaho National Lab, Aalo pursues parallel DOE and NRC pathways, betting that factory-built, pad-ready nuclear plants can slash cost, schedule, and grid-interconnection delays. Now 45 teammates strong and raising a Series B, Aalo aims to break ground on its first plant within 12 months and go critical the year after, powering the AI era with compact, clean, always-on fission.In this episode, we cover: [02:31] From SaaS to fission: Matt's founder journey[07:08] Yasir's path and the Marvel reactor at INL[08:56] How national labs help launch commercial nuclear[12:12] Aalo's dual regulatory path: DOE + NRC[13:45] Why Aalo is building reactors for data centers[17:19] Designing for mass manufacturing, not megaprojects[21:50] Security differences across nuclear facility types[25:03] Fuel and enrichment: what Aalo had to consider[28:02] Switching to LEU+ for supply chain resilience[31:04] Comparing XMRs, SMRs, and micro‑reactors[33:25] Inside the Aalo Pod: 5 x 10MW modules with built-in redundancy[37:15] Regulatory updates on NRC civilian licensing[38:43] Nuclear + AI: mutually transformative technologies[41:35] Hiring at Aalo: who they need nextEpisode recorded on April 23, 2025 (Published on May 19, 2025) Enjoyed this episode? Please leave us a review! Share feedback or suggest future topics and guests at info@mcj.vc.Connect with MCJ:Cody Simms on LinkedInVisit mcj.vcSubscribe to the MCJ Newsletter*Editing and post-production work for this episode was provided by The Podcast Consultant
Send us a textIn this episode of the Advancing Surgical Care Podcast, ASCA Chief Executive Officer Bill Prentice talks with Robert Saltaformaggio, senior counsel at Liles Parker, a Washington, DC-based law firm that focuses on regulatory healthcare compliance and reimbursement issues. Saltaformaggio is also a certified professional coder who assists ASCs and other healthcare providers with Medicare and Medicaid payer coverage and payment requirements, as well as claims disputes with major payers such as the various Blue Cross Blue Shield entities and UnitedHealthcare. During their discussion, Prentice and Saltaformaggio talk about the current regulatory landscape, the role of AI, the importance of conducting self-audits and more.
Welcome to a strange new world.Recent tariffs announced by the Trump Administration are likely to impact drug manufacturing, since many drug components are produced outside the U.S., in nations such as in India, giving rise to state laws. Many states limit overseas involvement relative to the Health Insurance Portability and Accountability Act (HIPAA). Florida, for example, prohibits the offshoring of certain patient data, requiring such storage to be within the U.S.Responding to this emerging crisis, the producers of RACmonitor and Monitor Mondays have invited Lexi Morrison, director of operations at MedPharma, to be the program's special guest during the next live edition of the venerable Internet broadcast, coming up at 10 a.m. EST on Monday, May 19.The long-running broadcast will also include these instantly recognizable features:• Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.• The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.• Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.• Legislative Update: Adam Brenman, senior government affairs analyst for Zelis, will report on the news happening at the intersection of healthcare and congressional action.
The ability to effectively manage and optimise data is key in an organisation today. But with the sheer volume and complexity of enterprise data, traditional methods are struggling to keep up with the change. This is where the agentic AI approach has swooped in to transform how organisations handle their most valuable resource. "The promise of AI and agentic AI is that we're now building very meaningful automation into the platform such that these teams of 10 are now able to basically actually capture all of the metadata about all of the data cataloged across their entire company," stated Corey Keyser, the head of artificial intelligence (AI) at Ataccama.In this episode of the Tech Transformed podcast, Shubhangi Dua, a B2B tech journalist and Podcast host at EM360Tech speaks with Keyser from Ataccama, about agentic AI, data quality, and data governance. They explore how intelligent automation is shaping enterprise data management, the role of AI in improving data quality, and the importance of trust in AI systems. Additionally, Keyser shares significant insights on Ataccama's unique approach to data governance, practical applications of their AI agent, and how they are keeping pace with the constantly changing AI regulations. While the speed and efficiency of AI are undeniable, the question of trust remains. Keyser addressed this directly: "The short answer is you can never fully trust these automations, right? “That's why it's really critical to always have data stewards that we will serve. We will always have data engineers that we will serve. We're just looking to improve their productivity. We always assume that there will be humans in the loop who are verifying the tasks orchestrated by AI agents."Ataccama's One AI Agent exemplifies the practical application of these principles. Keyser added that the AI agent can go and create data quality rules in bulk. “Go through the evaluation and testing of those quality rules in bulk, and then also assign the rules in bulk. Something that would take potentially weeks, can now actually kind of take hours depending on the person."TakeawaysAgentic AI is about dynamic planning and semi-autonomous task execution.Data governance involves cataloging and managing organisational data.Data quality assessment is crucial for ensuring high trust in data.AI can significantly speed up the creation of data quality rules.Human oversight is essential in AI-driven automation processes.Atacama's AI agent improves productivity for data management teams.Regulatory compliance is a growing concern for AI applications.User experience is key to successful AI integration in organisations.The relationship between data and AI is symbiotic and essential.Organisations must adapt to evolving AI regulations and standards.Chapters00:00 Introduction to Agentic AI and Data Governance02:41 Understanding Data Quality
This week on the Lancaster Farming Industrial Hemp Podcast, host Eric Hurlock wrestles with a question at the heart of the industry: What is hemp? The term has become increasingly diluted and controversial — especially in light of smokable flower and intoxicating cannabinoid markets, i.e. THC-a flower, Delta-8, etc. Lately, Eric has been saying that if you're growing floral hemp, maybe you're not actually a hemp farmer. But he might be wrong and this week he goes on a journey to find out. On this show, Eric speaks with three trusted voices on the cannabinoid side of the conversation to help untangle the confusion: Joe Ullman of Atlas Seed, Ben Davies of Wild Fox Provisions and Jeremy Klettke of Davis Hemp Farms. Together, they explore the cultural history, legal definitions and evolving market forces that have transformed how we use — and misuse — the word hemp. From fiber and grain to cannabinoids and regulation, this episode digs deep into the meaning, the consequences and the potential for redefining the future of the hemp industry. Learn More: • Joe Ullman – Atlas Seed • Ben Davies – Wild Fox Provisions • Jeremy Klettke – Davis Hemp Farms Topics Covered: • The origin and historical meaning of "hemp" • How the 2018 Farm Bill broadened the definition • The rise of THCa flower and "intoxicating hemp" • The conflict between cannabinoid and fiber/grain sectors • Regulatory confusion and COA loopholes • The cultural baggage of the word "hemp" • The role of education, infrastructure, and language in shaping the industry Hemp Sponsors: • IND HEMP — Building real infrastructure for American hemp • King's AgriSeeds — Call Sarah Mitchell for seasonal seed needs (717-687-6224) • Forever Green — Distributor of the KP4 hemp cutter Questions or comments? Email: podcast@lancasterfarming.com This episode was written, recorded, edited, and produced by Eric Hurlock and Justin Berger. © 2025 Lancaster Farming Newspaper, part of the Steinman Communications family.
Late on Friday the Waitangi Tribunal released its interim report into the proposed Regulatory Standards Bill.
In this episode, Cecile van der Heijden will disclose all the secret of the EHDS or European Health Data Space law. We will talk about the impact on Medical Device manufacturers but also on you as a human being as all this is about manipulation of data. Personal data or anonymized data. But can it be un-anonymized… Listen to this episode. Who is Cecile van der Heijden? Cécile van der Heijden is a senior legal expert at Axon Lawyers, a boutique law firm based in the Netherlands specialized in legal and regulatory affairs for the life sciences sector. With a strong focus on digital health, data protection, and medical device law, Cécile advises companies on navigating complex European regulations such as the MDR, GDPR, and the newly adopted European Health Data Space (EHDS) Regulation. She regularly supports clients developing AI, software as a medical device (SaMD), and connected technologies, helping them align innovation with compliance. Known for her practical approach, Cécile frequently speaks at conferences and publishes insights on digital health law across the EU. Who is Monir El Azzouzi? Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland. Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more. Link Cecile van der Heijden LinkedIn Profile: https://www.linkedin.com/in/cevanderheijden/ Axon Lawyers website: https://www.axonlawyers.com/ EHDS: https://www.european-health-data-space.com/ Article EHDS: https://www.consilium.europa.eu/en/press/press-releases/2025/01/21/european-health-data-space-council-adopts-new-regulation-improving-cross-border-access-to-eu-health-data/ Social Media to follow Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi Twitter: https://twitter.com/elazzouzim Pinterest: https://www.pinterest.com/easymedicaldevice Instagram: https://www.instagram.com/easymedicaldevice Authorized Representative and Importer services: https://easymedicaldevice.com/authorised-representative-and-importer/
00:03:58:22 - 00:09:55:09Rising incidents of truck crashes (e.g., Austin I-35, Thomasville, Alabama) linked to unqualified drivers, often immigrants on work visas.Ghost carriers operate with fake addresses (e.g., pizza joint in Illinois, apartment complex in Dallas), enabling fraud and theft.Lack of proper training and oversight, with companies prioritizing cost over safety, leading to loss of lives and national security concerns.00:21:17:19 - 00:24:09:18Nissan plans to cut 20,000 jobs (15% of workforce) by 2027, including 9,000 previously announced, and scale back production.Speculation: Cuts driven by uncertainty in North American market (38% of sales, US 27%), fearing economic collapse.Regulatory pressures (e.g., EPA standards, electric vehicles) also impact car industry.00:31:26:05 - 00:36:12:20China benefits from combat testing in India-Pakistan conflict; military-industrial complex (e.g., Raytheon, Lockheed Martin) profits from wars.US diplomacy (Trump, Vance, Rubio) mediated a ceasefire after four days of nuclear-armed conflict, highlighting neutral mediation success.Neither side uses US weapons, reducing American incentive to prolong conflict.00:41:24:03 - 00:47:19:25In the 1970s, psych meds were status symbols for the wealthy; now mainstream, fueling a massive industry.Mental health issues (e.g., depression, transgender identity) are used as social hierarchy markers, elevating perceived victims.Overuse of meds (e.g., SSRIs) linked to dangerous side effects, including violent behavior, with therapy culture promoting dependency.00:59:21:10 - 01:00:46:2024-hour news cycle promotes constant fear to control populations, making people more compliant and willing to relinquish liberties.Despite statistical safety, media amplifies threats, fostering anxiety.01:09:59:09 - 01:18:23:25Trump's “Generation Gold Standard” aims for a universal flu vaccine using outdated whole killed virus technology, costing $500 million.Contradicts anti-vaccine rhetoric (e.g., RFK Jr.'s stance), raising concerns about corporate influence and potential harm.Critique of vaccine industry: excessive childhood vaccines (up to 76), harmful side effects, and systemic pressure on doctors to comply.01:29:39:03 - 01:35:47:13Pew Research shows Gen Z men attending religious services more than millennials/Gen X, closing gender gap as young women leave churches.Post-Covid isolation drives youth to seek community and meaning in faith, countering atheism's cultural decline.Focus on eternal significance of faith over political impact.01:42:00:29 - 01:43:25:00Man exonerated by DNA evidence after nearly four decades, despite proper legal procedures.Emphasizes need for due process to prevent such errors, as abandoning it risks widespread injustice.01:49:13:12 - 01:54:23:11Trump grants refugee status to 60 white South African farmers fleeing state-sanctioned persecution, criticized as racially biased.Argues for prioritizing refugees from cultures aligning with American values, citing South Africans' work ethic and liberty focus.Contrasts with open-border policies, highlighting selective immigration's role in preserving national identity.02:05:31:08 - 02:15:57:16Government funding for “school choice” (e.g., $5,000-$7,000 per student in Tennessee, Idaho, Wyoming) comes with strings, pushing state-approved curricula and control.UNESCO promotes universal government funding to integrate private and homeschooling into public systems, per Alex Newman.Tennessee's failed “free act” shows resistance to homeschool autonomy; Texas Homeschool Coalition criticized for supporting funding.02:16:23:28 - 02:19:36:02Passed April 10, 2025, requiring autopsies to document psychotropic drug use (e.g., SSRIs) in mass shooters, spurred by Nashville school shooting.Aims to study drug interactions and disclose findings publicly, addressing links between SSRIs and violent behavior.Highlights exacerbation of mental health issues by pharmaceuticals, as seen in the shooter's worsening condition.02:20:04:24 - 02:47:31:19“Cold Case Christianity” graphic novel, co-authored with son, follows detectives chasing a serial killer, subtly exploring human value from a Christian perspective.Challenges secular views equating humans with animals, emphasizing humans as God's image-bearers with inherent dignity.Designed as a gateway for non-Christians, includes QR code for resurrection case booklet and resources at coldcasechristianity.com.Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.comIf you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.
00:03:58:22 - 00:09:55:09Rising incidents of truck crashes (e.g., Austin I-35, Thomasville, Alabama) linked to unqualified drivers, often immigrants on work visas.Ghost carriers operate with fake addresses (e.g., pizza joint in Illinois, apartment complex in Dallas), enabling fraud and theft.Lack of proper training and oversight, with companies prioritizing cost over safety, leading to loss of lives and national security concerns.00:21:17:19 - 00:24:09:18Nissan plans to cut 20,000 jobs (15% of workforce) by 2027, including 9,000 previously announced, and scale back production.Speculation: Cuts driven by uncertainty in North American market (38% of sales, US 27%), fearing economic collapse.Regulatory pressures (e.g., EPA standards, electric vehicles) also impact car industry.00:31:26:05 - 00:36:12:20China benefits from combat testing in India-Pakistan conflict; military-industrial complex (e.g., Raytheon, Lockheed Martin) profits from wars.US diplomacy (Trump, Vance, Rubio) mediated a ceasefire after four days of nuclear-armed conflict, highlighting neutral mediation success.Neither side uses US weapons, reducing American incentive to prolong conflict.00:41:24:03 - 00:47:19:25In the 1970s, psych meds were status symbols for the wealthy; now mainstream, fueling a massive industry.Mental health issues (e.g., depression, transgender identity) are used as social hierarchy markers, elevating perceived victims.Overuse of meds (e.g., SSRIs) linked to dangerous side effects, including violent behavior, with therapy culture promoting dependency.00:59:21:10 - 01:00:46:2024-hour news cycle promotes constant fear to control populations, making people more compliant and willing to relinquish liberties.Despite statistical safety, media amplifies threats, fostering anxiety.01:09:59:09 - 01:18:23:25Trump's “Generation Gold Standard” aims for a universal flu vaccine using outdated whole killed virus technology, costing $500 million.Contradicts anti-vaccine rhetoric (e.g., RFK Jr.'s stance), raising concerns about corporate influence and potential harm.Critique of vaccine industry: excessive childhood vaccines (up to 76), harmful side effects, and systemic pressure on doctors to comply.01:29:39:03 - 01:35:47:13Pew Research shows Gen Z men attending religious services more than millennials/Gen X, closing gender gap as young women leave churches.Post-Covid isolation drives youth to seek community and meaning in faith, countering atheism's cultural decline.Focus on eternal significance of faith over political impact.01:42:00:29 - 01:43:25:00Man exonerated by DNA evidence after nearly four decades, despite proper legal procedures.Emphasizes need for due process to prevent such errors, as abandoning it risks widespread injustice.01:49:13:12 - 01:54:23:11Trump grants refugee status to 60 white South African farmers fleeing state-sanctioned persecution, criticized as racially biased.Argues for prioritizing refugees from cultures aligning with American values, citing South Africans' work ethic and liberty focus.Contrasts with open-border policies, highlighting selective immigration's role in preserving national identity.02:05:31:08 - 02:15:57:16Government funding for “school choice” (e.g., $5,000-$7,000 per student in Tennessee, Idaho, Wyoming) comes with strings, pushing state-approved curricula and control.UNESCO promotes universal government funding to integrate private and homeschooling into public systems, per Alex Newman.Tennessee's failed “free act” shows resistance to homeschool autonomy; Texas Homeschool Coalition criticized for supporting funding.02:16:23:28 - 02:19:36:02Passed April 10, 2025, requiring autopsies to document psychotropic drug use (e.g., SSRIs) in mass shooters, spurred by Nashville school shooting.Aims to study drug interactions and disclose findings publicly, addressing links between SSRIs and violent behavior.Highlights exacerbation of mental health issues by pharmaceuticals, as seen in the shooter's worsening condition.02:20:04:24 - 02:47:31:19“Cold Case Christianity” graphic novel, co-authored with son, follows detectives chasing a serial killer, subtly exploring human value from a Christian perspective.Challenges secular views equating humans with animals, emphasizing humans as God's image-bearers with inherent dignity.Designed as a gateway for non-Christians, includes QR code for resurrection case booklet and resources at coldcasechristianity.com.Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.comIf you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.
In this episode, Bryan Nelson is back for another insightful conversation about the trucking and language laws, and today, he talks about English proficiency requirements for commercial drivers and recent legal and regulatory changes! Here's What to Learn From This Episode: English Proficiency Requirements: Overview of 49 CFR 391.11, B2 emphasizes that drivers must read and speak English to interact with the public and understand road signs; historical enforcement aimed to be employer-based. Concerns raised by ACLU and EEOC about civil rights implications during 1997 proposed rulemaking. Recent Executive Actions: April 28 Executive Order 14286 mandates FMCSA to enforce English proficiency within 60 days; CVSA reinstates out-of-service criterion. Regulatory landscape shifts toward roadside inspections, raising concerns about subjective enforcement by officers across states, affecting consistency and compliance. Operational Risks & Compliance Strategies: Increased potential for fines (500 first offense, 1,000 subsequent) and business disruption due to English proficiency violations - influencing insurance coverages. Recommended strategies for carriers include proactive English training, updating compliance procedures, and monitoring regulatory developments closely to mitigate legal risks and business impacts. About Bryan Nelson Bryan J. Nelson is a transportation and logistics attorney assisting clients in the development and review of transportation agreements, the resolution and mitigation of cargo claims, and the establishment of corporate compliance strategies in accordance with state and federal regulations. Prior to joining Taylor Nelson, Bryan practiced as general counsel and served as a chief administrative officer in the transportation industry for over a decade, representing a family of companies that included a motor carrier, a third-party logistics corporation, and a transportation management system (TMS) provider. Bryan graduated from Stetson University earning his juris doctorate and his master's degree in business administration. He received his undergraduate degrees in Accounting and Finance from Florida State University. With his hands-on experience in the transportation industry, Bryan recognizes and understands the unique challenges and opportunities facing transportation companies throughout the supply chain. Connect with Bryan LinkedIn: https://www.linkedin.com/in/bryan-j-nelson-esq-mba-59876b1b/ Email: bnelson@taylorlawpl.com
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we sat down with Dr. Arun Menawat, Chairman and CEO of Profound Medical. Profound is commercializing the TULSA-PRO system, an alternative approach to prostate cancer treatment that uses MRI-guided thermal ultrasound to target and eliminate cancerous tissue without surgical incisions. Before joining Profound in 2016, Arun served as the Chairman and CEO of Novadaq Technologies for 13 years, guiding the company from a startup to one of the fastest-growing, NASDAQ-listed medical technology businesses with a market cap exceeding one billion USD. Earlier in his career, Arun served as President of Cedara Software, a company that developed the industry's first medical imaging software platform. Today, it's part of IBM's Watson Health.In this interview, Arun shares insights on building credibility with physicians, the strategic approach to clinical trials that led to their recent Medicare reimbursement coverage, and his vision for transforming the future of surgery beyond prostate cancer.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Arun Menawat.
AI is reshaping the future of medical devices, but innovation brings complexity. In this episode of AI Issue Spotting, Scott Loughlin is joined by fellow Hogan Lovells Medical Device and Technology partners Michael Heyl and Jodi Scott to explore the challenges companies face as AI begins to monitor medical device performance, diagnose conditions, and even deliver patient care. From regulatory hurdles to liability risks, they discuss how medical device manufacturers can navigate this rapidly evolving space. With AI blurring the lines between traditional medical devices and new digital solutions, the discussion highlights what medical device businesses need to know to stay compliant and innovative.
Claimants in an urgent Waitangi Tribunal hearing say the ACT Party's Regulatory Standards Bill is a more aggressive and stealthier version of the Treaty Principles Bill. Their lawyers presented evidence to the Tribunal on Wednesday in a tight, online-only, hearing that had to be pushed forward by 3 weeks. Maori news journalist Tuwhenuaroa Natanahira filed this report.
Critics have told the Waitangi Tribunal that the ACT Party's Regulatory Standards Bill is, in fact, an anti-Treaty Bill. Māori News Journalist Pokere Paewai reports.
Microsoft (MSFT) shares are just below 2025-highs after a huge post-earnings rally. The company's up 30% from 52-week lows hit in early April. Caroline Woods notes a report adding to MSFT's upward move today, suggesting the Big Tech giant is revising its partnership with ChatGPT's parent company, OpenAI, ahead of a potential IPO. That said, regulation headwinds can challenge MSFT stock's run to a new all-time high.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about
Send us a textJoin host Aaron Moncur as he sits down with Dr. Stuart Grant, a seasoned med tech innovator with over 25 years of experience at industry giants like Johnson & Johnson and DePuy. Dr. Grant shares his journey from design engineering to founding his own consultancy, offering invaluable insights into medical device development, regulatory challenges, and the future of medical technology.Main Topics:Career progression in medical device engineeringChallenges of starting a medical tech consultancyRegulatory differences across global marketsInnovation strategies in medical technologyAdvice for young engineersFuture trends in surgical robotics and AIAbout the guest: Dr. Stuart Grant is a seasoned expert in the MedTech industry with over 20 years of experience at major companies like Johnson & Johnson and DePuy Synthes. In 2023, he founded Archetype MedTech, a consultancy that helps medical device companies achieve market approval through innovation strategy, technical evaluations, and team training. He holds advanced innovation and project management degrees and is a Chartered Engineer with several medical device patents. In addition to his technical work, Stuart lectures on innovation history and is a visual artist. His international experience and multidisciplinary expertise make him a key advisor for MedTech startups and scale-ups.Links:Dr. Stuart Grant - LinkedIn Archetype MedTech Website The Idea Factory: Bell Labs and the Great Age of American InnovationExactly How Precision Engineers Created the Modern World
Your best new tenant might be sitting right above your head. On this episode of Retail Retold, Chris Ressa is joined by Bill Fitzgerald of Radial Power to reveal a game-changing secret for retail landlords: your rooftop is prime real estate. Backed by industry heavyweights like Starwood and Related, Radial Power is turning unused roof space into pure NOI with zero CapEx. Forget about just cutting costs—solar is adding revenue streams, hitting ESG goals, and future-proofing properties.Bill breaks down how Radial operates as a tenant, not just a service, paying you for your roof space and handling everything from installation to energy sales. This is rooftop leasing redefined, and it's supercharging the balance sheets of forward-thinking landlords.Ready to make your roof work for you? Tune in now.TakeawaysBill Fitzgerald has been in solar for about seven years.Radial Power helps drive sustainability through rooftop solar.Solar can drive value add and increase net operating income (NOI).There are two main ways to operate solar on properties: ownership or leasing.Radial Power operates as a rooftop tenant, managing all costs and risks.Monetization of solar includes selling electricity and environmental credits.Regulatory environments significantly impact solar operations and pricing.Solar energy is geographically sensitive due to varying regulations.Solar providers like Radial Power are often misunderstood as sellers of solar systems.Solar installations can create additional NOI without upfront capital expenditures.Chapters00:00 Introduction to Solar and Retail Real Estate02:45 Understanding Radial Power's Mission04:56 Exploring Solar Ownership Models08:47 Monetizing Solar Assets13:39 Regulatory Challenges in Solar Energy
In this episode, hosts Brad and Michael, along with series regular Jay Reyero, share the story of an orthopedic surgeon and the unintended consequence of landing his dream job as team physician for a top college football program. As new NIL (Name, Image, Likeness) rules reshaped college sports, student athletes can seek compensation beyond traditional medical expenses, increasing a surgeon's malpractice exposure. Tune in to learn how legal and regulatory shifts in health care, especially those outside your control, can quietly impact your practice, and the steps you can take to protect yourself from unexpected risks. Watch full episodes of our podcast on our YouTube channel:https://www.youtube.com/@byrdadatto Stay connected for the latest business and health care legal updates:WebsiteFacebookInstagramLinkedIn
It's Newsday Tuesday. Up top, Sam and Emma take in the White House's angry response to the news that Amazon had started to display the cost of tariffs on it's orders on one of its websites, before Amazon quickly back-peddled and apologized. Sam and Emma then talk to the former head of the CFPB and the FTC Rohit Chopra on the Trump administration taking a sledgehammer to regulations and consumer protections. After that, Canadian writer and podcaster Luke Savage breaks down the results of Canada's elections and what it means for the future of Canada-U.S. relations. Follow his Substack: https://www.lukewsavage.com/ As well as his delightful film podcast Michael and Us: https://podcasts.apple.com/us/podcast/michael-and-us/id1120756155 In the Fun Half, Emma and Sam check in on Trump's nominee for U.S. attorney in Washington, DC Ed Martin and his efforts to distance himself from his right wing media appearances, including his repeated praise of a January 6th rioter and apparent Nazi sympathizer. Meanwhile, Chuck Schumer says he's sent a strongly worded letter to the Trump administration over their crackdown on academia, but also goes out of his way to denounce what he said were antisemitic incidents on college campuses. Andrew Callaghan tries to talk some sense into Patrick Bet-David regarding the relationship between homelessness, social welfare programs and taxation, to no avail. Become a member at JoinTheMajorityReport.com: https://fans.fm/majority/join Follow us on TikTok here!: https://www.tiktok.com/@majorityreportfm Check us out on Twitch here!: https://www.twitch.tv/themajorityreport Find our Rumble stream here!: https://rumble.com/user/majorityreport Check out our alt YouTube channel here!: https://www.youtube.com/majorityreportlive Gift a Majority Report subscription here: https://fans.fm/majority/gift Subscribe to the ESVN YouTube channel here: https://www.youtube.com/esvnshow Subscribe to the AMQuickie newsletter here: https://am-quickie.ghost.io/ Join the Majority Report Discord! https://majoritydiscord.com/ Get all your MR merch at our store: https://shop.majorityreportradio.com/ Get the free Majority Report App!: https://majority.fm/app Go to https://JustCoffee.coop and use coupon code majority to get 10% off your purchase! Check out today's sponsors: Babel: Babbel.com/Majority for up to 60% off your subscription Fast Growing Trees: Get 15% off your first purchase. FastGrowingTrees.com/majority Aura Frames: Exclusive $35-off Carver Mat at AuraFrames.com. Promo Code MAJORITY Follow the Majority Report crew on Twitter: @SamSeder @EmmaVigeland @MattLech @RussFinkelstein Check out Matt's show, Left Reckoning, on Youtube, and subscribe on Patreon! https://www.patreon.com/leftreckoning Check out Matt Binder's YouTube channel: https://www.youtube.com/mattbinder Subscribe to Brandon's show The Discourse on Patreon! https://www.patreon.com/ExpandTheDiscourse Check out Ava Raiza's music here! https://avaraiza.bandcamp.com/ The Majority Report with Sam Seder – https://majorityreportradio.com/